Histological grade provides significant prognostic information in addition to breast cancer subtypes defined according to St Gallen 2013. (Q39267625)

10 September 2017

title

Histological grade provides significant prognostic information in addition to breast cancer subtypes defined according to St Gallen 2013. (English)

1 reference

10 September 2017

2

Per Malmström

1 reference

10 September 2017

9

Olle Stål

1 reference

10 September 2017

Anna Ehinger

1

1 reference

10 September 2017

Pär-Ola Bendahl

3

1 reference

10 September 2017

Christopher W Elston

4

1 reference

10 September 2017

Anna-Karin Falck

5

1 reference

10 September 2017

Carina Forsare

6

1 reference

10 September 2017

Dorthe Grabau

7

1 reference

10 September 2017

Lisa Rydén

8

1 reference

10 September 2017

Mårten Fernö

10

1 reference

10 September 2017

South and South-East Swedish Breast Cancer Groups

11

1 reference

10 September 2017

publication date

20 October 2016

1 reference

10 September 2017

1 reference

10 September 2017

volume

56

1 reference

10 September 2017

issue

1

1 reference

10 September 2017

page(s)

68-74

1 reference

International Web-based consultation on priorities for translational breast cancer research

10 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F0284186X.2016.1237778

Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0284186X.2016.1237778

Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0284186X.2016.1237778

The Nottingham Prognostic Index applied to 9,149 patients from the studies of the Danish Breast Cancer Cooperative Group (DBCG).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0284186X.2016.1237778

Breast cancer prognostic classification in the molecular era: the role of histological grade

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0284186X.2016.1237778

Histologic grade remains a prognostic factor for breast cancer regardless of the number of positive lymph nodes and tumor size: a study of 161 708 cases of breast cancer from the SEER Program

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0284186X.2016.1237778

Two years of adjuvant tamoxifen in premenopausal patients with breast cancer: a randomised, controlled trial with long-term follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0284186X.2016.1237778

Comparison of immunohistochemical and biochemical assay of steroid receptors in primary breast cancer--clinical associations and reasons for discrepancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0284186X.2016.1237778

Analysis of and prognostic information from disseminated tumour cells in bone marrow in primary breast cancer: a prospective observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0284186X.2016.1237778

S-phase fraction and urokinase plasminogen activator are better markers for distant recurrences than Nottingham Prognostic Index and histologic grade in a prospective study of premenopausal lymph node-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0284186X.2016.1237778

Proposed new clinicopathological surrogate definitions of luminal A and luminal B (HER2-negative) intrinsic breast cancer subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0284186X.2016.1237778

Molecular subtypes, histopathological grade and survival in a historic cohort of breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0284186X.2016.1237778

PAM50 breast cancer subtyping by RT-qPCR and concordance with standard clinical molecular markers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0284186X.2016.1237778

Intrinsic breast cancer subtypes defined by estrogen receptor signalling-prognostic relevance of progesterone receptor loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0284186X.2016.1237778

Progesterone receptor expression is an independent prognostic variable in early breast cancer: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0284186X.2016.1237778

Prognostic significance of progesterone receptor-positive tumor cells within immunohistochemically defined luminal A breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0284186X.2016.1237778

Histologic grading in breast cancer--reproducibility between seven pathologic departments. South Sweden Breast Cancer Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0284186X.2016.1237778

Histologic grading of breast carcinoma. A reproducibility study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0284186X.2016.1237778

Impact of a national external quality assessment scheme for breast pathology in the UK

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0284186X.2016.1237778

American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0284186X.2016.1237778

An international Ki67 reproducibility study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0284186X.2016.1237778

10.1080/0284186X.2016.1237778

21 January 2018

Identifiers

DOI

1 reference

release_2pianecohvfgtlsl7y3kyn4b2a

10 September 2017

Fatcat ID

0 references

1 reference